Roshandel, G., Ghasemi-Kebria, F. & Malekzadeh, R. Colorectal cancer: epidemiology, risk factors, and prevention. Cancers 16, 1530 (2024).
Google Scholar
Yang, Z. et al. Molecular complexity of colorectal cancer: pathways, biomarkers, and therapeutic strategies. Cancer Manag Res. 16, 1389–1403 (2024).
Google Scholar
Raut, P., Mathivanan, P., Batra, S. K. & Ponnusamy, M. P. Contract to kill: GNAS mutation. Mol. Cancer. 24, 70 (2025).
Google Scholar
Ohtsuka, T. et al. Clinical assessment of the GNAS mutation status in patients with intraductal papillary mucinous neoplasm of the pancreas. Surg. Today. 49, 887–893 (2019).
Google Scholar
Weinstein, L. S., Liu, J., Sakamoto, A., Xie, T. & Chen, M. GNAS: normal and abnormal functions. Endocrinology 145, 5459–5464 (2004).
Google Scholar
Landis, C. A. et al. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 340, 692–696 (1989).
Google Scholar
Molin, M. D. et al. Clinicopathological correlates of activating GNAS mutations in intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Ann. Surg. Oncol. 20, 3802–3808 (2013).
Google Scholar
Jang, S. et al. High throughput molecular profiling reveals differential mutation patterns in intrahepatic cholangiocarcinomas arising in chronic advanced liver diseases. Mod. Pathol. 27, 731–739 (2014).
Google Scholar
Wang, C., Sandhu, J. & Fakih, M. Mucinous histology is associated with resistance to Anti-EGFR therapy in patients with Left-Sided RAS/BRAF Wild-Type metastatic colorectal cancer. Oncologist 27, 104–109 (2022).
Google Scholar
Zauber, P., Marotta, S. P. & Sabbath-Solitare, M. GNAS gene mutation May be present only transiently during colorectal tumorigenesis. Int. J. Mol. Epidemiol. Genet. 7, 2431 (2016).
Afolabi, H. et al. A systematic review and meta-analysis on the occurrence of biomarker mutation in colorectal cancer among the Asian population. Biomed Res Int 2022:5824183. (2022).
Ramms, D. J. et al. Gαs-Protein kinase A (PKA) pathway signalopathies: the emerging genetic landscape and therapeutic potential of human diseases driven by aberrant Gαs-PKA signaling. Pharmacol. Rev. 73, 155–197 (2021).
Google Scholar
Jung, H. et al. Associations of GNAS mutations with surgical outcomes in patients with growth Hormone-Secreting pituitary adenoma. Endocrinol. Metab. (Seoul). 36, 342–350 (2021).
Google Scholar
Patra, K. C. et al. Mutant GNAS drives pancreatic tumourigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolism. Nat. Cell. Biol. 20, 811–822 (2018).
Google Scholar
Afolabi, H. A. et al. A GNAS gene mutation’s independent expression in the growth of colorectal cancer: A systematic review and Meta-Analysis. Cancers (Basel). 14, 5480 (2022).
Google Scholar
Fecteau, R. E., Lutterbaugh, J., Markowitz, S. D., Willis, J. & Guda, K. GNAS mutations identify a set of right-sided, RAS mutant, villous colon cancers. PloS One. 9, e87966 (2014).
Google Scholar
Polani, F., Swain, W., Se, B., Randall, J. & Cannon, T. Prognostic implications and therapeutic response in GNAS-mutated colorectal adenocarcinoma: A retrospective cohort analysis. J. Clin. Oncol. 43, 244 (2025).
Taylor, C. F. Mutation scanning using high-resolution melting. Biochem. Soc. Trans. 37, 433–437 (2009).
Google Scholar
Rao, R., Salloum, R., Xin, M. & Lu, Q. R. The G protein Gαs acts as a tumor suppressor in Sonic Hedgehog signaling-driven tumorigenesis. Cell. Cycle. 15, 1325–1330 (2016).
Google Scholar
O’Hayre, M., Degese, M. S. & Gutkind, J. S. Novel insights into G protein and G protein-coupled receptor signaling in cancer. Curr. Opin. Cell. Biol. 27, 126–135 (2014).
Google Scholar